Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Menarini IFR – International Division

Femme et Homme Max 99 ans
Menarini IFR – International Division MAJ Il y a 4 ans

Otilonium Bromide in Irritable Bowel Syndrome – (OBIS) Double blind, randomized, parallel group, placebo-controlled study to evaluate the effect of otilonium bromide on abdominal pain and quality of life in patients with irritable bowel syndrome Barostat sub-study: Effect of otilonium bromide versus placebo on the perception of rectal distension in patients with irritable bowel syndrome (IBS) Confirm efficacy of otilonium bromide for symptom control (frequency of abdominal pain in patients with irritable bowel syndrome (IBS) in a superiority trial versus placebo.

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations